AIM2 and hepatocellular carcinoma: In the context of an inflammasome-dependent function, AIM2 can be activated by circulating dsDNA in the serum of mice treated with the carcinogen diethylnitrosamine, which promotes inflammasome-mediated inflammation and hepatocellular carcinoma progression [499].